# POLARITYTE, INC.: Form D filings

POLARITYTE, INC., a biotechnology company in Salt Lake City, UT, filed 4 Form D notices with the SEC between 2016 and 2022. The latest, on June 14, 2022, reports $4 million sold of a $11.6 million offering to 1 investor.

Find out what POLARITYTE, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20POLARITYTE%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=POLARITYTE%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fpolarityte-inc-1076682)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20POLARITYTE%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=POLARITYTE%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fpolarityte-inc-1076682)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Utah](https://specstream.ai/data/form-d/state/utah): 660 rows, by operating companies, filed since November 1, 2024, $33, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/utah
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1960 S. 4250 WEST, Salt Lake City, UT, 84104
- Phone: (800) 560-3983
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $5,000,001 - $25,000,000
- Exemptions claimed: Rule 506(c), Securities Act section 4(a)(5)
- SEC identifier (CIK): 1076682

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 14, 2022 | New notice | $11,603,965 | $3,998,417 | $7,605,548 | 1 | Jun 5, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1076682/000149315222016749/0001493152-22-016749-index.htm) |
| Sep 26, 2017 | New notice | $17,750,002 | $17,750,002 | $0 | 10 | Sep 20, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1076682/000149315217010920/0001493152-17-010920-index.htm) |
| Apr 10, 2017 | New notice | $1 | $1 | $0 | 1 | Apr 5, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1076682/000149315217003703/0001493152-17-003703-index.htm) |
| Dec 21, 2016 | New notice | $2,278,001 | $2,278,001 | $0 | 28 | Dec 16, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1076682/000149315216016089/0001493152-16-016089-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Chris Nolet | Director |  |
| Peter Cohen | Director |  |
| Jeffrey Dyer | Director |  |
| Cameron Hoyler | Executive Officer |  |
| Jacob Patterson | Executive Officer |  |
| Denver Lough | Promoter |  |
| David Seaburg | Director |  |
| Willie Bogan | Director |  |
| Richard Hague | Executive Officer |  |

## Other biotechnology companies in Utah that filed recently

- [Life Impact Partners 14 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-14-llc-2163022) offering · Nov 9, 2026
- [Life Impact Partners 15 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-15-llc-2163019) offering · Nov 9, 2026
- [Life Impact Partners 7 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-7-llc-2163024) offering · Nov 6, 2026
- [Life Impact Partners 6 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-6-llc-2163017) offering · Nov 6, 2026
- [Life Impact Partners 3 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-3-llc-2162995) offering · Nov 6, 2026
- [Life Impact Partners 5 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-5-llc-2162994) offering · Nov 6, 2026
- [Life Impact Partners 4 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-4-llc-2162993) offering · Nov 6, 2026
- [Life Impact Partners 2 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-2-llc-2162992) offering · Nov 6, 2026
- [Life Impact Partners 8 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-8-llc-2162973) offering · Nov 6, 2026
- [Life Impact Partners 1 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-1-llc-2154209) offering · Oct 22, 2026
- [3Helix, Inc.](https://specstream.ai/data/form-d/company/3helix-inc-2001622) $7.8 million · Sep 21, 2026
- [Halia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/halia-therapeutics-inc-1829255) $3.5 million · Aug 31, 2026
- [Paterna BioSciences HoldCo Inc.](https://specstream.ai/data/form-d/company/paterna-biosciences-holdco-inc-1989862) $6.3 million · Aug 12, 2026

[Every Form D from the week of Jun 13, 2022](https://specstream.ai/data/form-d/week/2022-06-13) · [All recent filings in Utah](https://specstream.ai/data/form-d/state/utah) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what POLARITYTE, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).